Brokerage firms currently have a positive stance on shares of TechTarget, Inc. (NASDAQ:TTGT). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. Those same analysts are projecting that the stock will reach $14.50 on a short term basis.
At the time of writing, the stock was trading at $14.61. This represents a change from most recent open price of 4.21%. In terms of performance, year to date, the stock is 4.96%. The monthly stock performance comes in at 9.03%. For the quarter, shares are performing at 20.64%. Weekly performance analysis shows the equity at 6.33%.
In taking a look at technical levels, shares are trading 7.80% away from the 50 day simple moving average and 33.12% away from the 200 day simple moving average. Based on a recent bid, the stock is trading 1.95% away from it’s 52- week high and 73.72% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, TechTarget, Inc.’s RSI stands at 64.18. In looking at volatility levels, the shares saw weekly volatility of 3.00% and 2.65% over the past month.
Equity Research firms currently have a positive stance on shares of BioTelemetry, Inc. (NASDAQ:BEAT). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.70. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $43.50 on a short term basis.
BioTelemetry, Inc. (NASDAQ:BEAT) shares typically trade an average volume of 554.94 and institutions hold 83.70% of the total shares.
We see here that the stock is 8.60% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of 17.76% from current levels. Further back, their 200-Day Simple Moving Average is 6.62% difference from today’s price. Currently, the stock is 2.31% from its 50-Day High and 42.27% from the 50-day low.
BioTelemetry, Inc. (NASDAQ:BEAT)‘s stock has performed at 10.87%. Breaking that down further, it has performed 5.57% for the week, 17.14% for the month, 3.59% over the last quarter, -3.63% for the past half-year and 53.83% for this last year.